Hjelt Diabetes Foundation supports research that can pave the way for new cell therapies
Sevda Gheibi studies a protein called ACSL1 that seems to play a key role for beta cell function. She receives a grant of from the Hjelt Diabetes Foundation for further studies of this protein. Photo: Petra Olsson Type 2 diabetes is a chronic disease that usually requires lifelong treatment. A central goal for many diabetes researchers is to develop new cell therapies that can cure the disease. Th
https://www.medicine.lu.se/article/hjelt-diabetes-foundation-supports-research-can-pave-way-new-cell-therapies - 2025-08-25